electroCore, Inc. Common Stock
Symbol: ECOR (NASDAQ)
4.95
▼ (-0.10%) -0.005
Company Description:
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Key Stats
- Today's Open: $4.92
- Today's High: $5.015
- Today's Low: $4.88
- Today's Volume: 20.33K
- Yesterday Close: $4.95
- Yesterday High: $5.04
- Yesterday Low: $4.8791
- Yesterday Volume: 29.17K
- Last Min Volume: 1
- Last Min High: $4.945
- Last Min Low: $4.945
- Last Min VWAP: $4.945
Company Profile
- Name: electroCore, Inc. Common Stock
- Website: https://www.electrocore.com
- Listed Date: 2018-06-22
- Location: ROCKAWAY, NJ
- Market Status: Active
- CIK Number: 0001560258
- SIC Code: 3845
- SIC description: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Market Cap: $37.54M
- Round Lot: 100
- Outstanding Shares: 7.58M
- Asset Type: CS
RECENT FILINGS FOR ECOR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-16 | D | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 3 | View |
| 2025-09-08 | SCHEDULE 13G | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-03 | 8-K | View |
| 2025-08-13 | 4 | View |
| 2025-08-12 | 4 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 3 | View |
| 2025-07-24 | EFFECT | View |
| 2025-07-22 | CORRESP | View |
| 2025-07-18 | CORRESP | View |
| 2025-07-18 | S-3/A | View |
Latest News on ECOR